» Authors » Louis Valiquette

Louis Valiquette

Explore the profile of Louis Valiquette including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 103
Citations 2510
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Pott H, Andrew M, Shaffelburg Z, Nichols M, Ye L, ElSherif M, et al.
Open Forum Infect Dis . 2025 Feb; 12(2):ofaf058. PMID: 39968306
Background: Oseltamivir is recommended for the treatment of adults hospitalized with influenza, but adherence is often suboptimal. This may be due to doubts about the reliability of the evidence supporting...
2.
Soe P, Vanderkooi O, Sadarangani M, Naus M, Muller M, Kellner J, et al.
Lancet Reg Health Am . 2024 Dec; 40:100949. PMID: 39659558
Background: The Canadian National Vaccine Safety Network conducted active safety surveillance for COVID-19 vaccines. This study aimed to characterize the short-to-medium term safety of mRNA COVID-19 vaccines across the pediatric...
3.
Fischer K, Langley J, Harrison R, Mubareka S, Nadarajah J, Smieja M, et al.
Int J Environ Res Public Health . 2024 Nov; 21(11). PMID: 39595768
Background: Essential workers, including those working in healthcare and education, are at higher risk of exposure to communicable diseases, including SARS-CoV-2. Reducing the rates of infection is important for their...
4.
Top K, Shulha H, Muller M, Valiquette L, Vanderkooi O, Kellner J, et al.
Vaccine . 2024 Oct; 42(26):126445. PMID: 39413493
Introduction: The Canadian National Vaccine Safety Network (CANVAS) conducted active participant-based surveillance for adverse events following immunization during the COVID-19 vaccine campaign. This study evaluated the association between COVID-19 vaccination...
5.
Coleman B, Gutmanis I, Bondy S, Harrison R, Langley J, Fischer K, et al.
Vaccine . 2024 Sep; 42(24):126271. PMID: 39226785
Background: The demand for COVID-19 vaccines has diminished as the pandemic lingers. Understanding vaccine hesitancy among essential workers is important in reducing the impact of future pandemics by providing effective...
6.
Soe P, Sadarangani M, Naus M, Muller M, Vanderkooi O, Kellner J, et al.
Front Public Health . 2024 Aug; 12:1385426. PMID: 39188790
Background: The Canadian National Vaccine Safety (CANVAS) network conducted a multi-center, prospective vaccine safety study to collect safety data after dose 1 and 2 of COVID-19 vaccines and follow up...
7.
Soe P, Wong H, Naus M, Muller M, Vanderkooi O, Kellner J, et al.
Vaccine . 2024 May; 42(18):3819-3829. PMID: 38714447
This study examined short-to-medium term safety of COVID-19 vaccines among adults aged ≥65 years using the Canadian National Vaccine Safety Network active safety surveillance data. Both vaccinated and unvaccinated older...
8.
Abou Chakra C, Gagnon A, Lapointe S, Granger M, Levesque S, Valiquette L
Open Forum Infect Dis . 2024 Mar; 11(3):ofae085. PMID: 38524230
Background: The association between bacterial strains and clinical outcomes in infection (CDI) has yielded conflicting results across studies. We conducted a systematic review and meta-analyses to assess the impact of...
9.
Pott H, Andrew M, Shaffelburg Z, Nichols M, Ye L, ElSherif M, et al.
Vaccine . 2023 Sep; 41(42):6359-6365. PMID: 37696717
Background: Influenza vaccines prevent influenza-related morbidity and mortality; however, suboptimal vaccine effectiveness (VE) of non-adjuvanted trivalent inactivated influenza vaccine (naTIV) or quadrivalent formulations in older adults prompted the use of...
10.
Granger M, Kelly M, Fortier L, Fournier E, Cote-Gravel J, Malouin F, et al.
Clin Infect Dis . 2023 Jul; 77(12):1700-1703. PMID: 37477511
Klebsiella oxytoca is a gram-negative bacterium found in fecal microbiota and known to cause several infections in humans, including antibiotic-associated hemorrhagic colitis. We present here a case of colitis caused...